| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |